🇺🇸 FDA
Patent

US 10597415

Pentaaza macrocyclic ring complexes possessing oral bioavailability

granted A61KA61K31/28A61K31/555

Quick answer

US patent 10597415 (Pentaaza macrocyclic ring complexes possessing oral bioavailability) held by Galera Labs, LLC expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Galera Labs, LLC
Grant date
Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/28, A61K31/555, A61K47/14, A61K47/38